New blood test developed to diagnose Parkinson’s disease

A new blood test has been developed that could help doctors to diagnose Parkinson’s disease without being as invasive as previous methods. It uses a newly discovered protein, which when found in the blood denotes the presence of the disease.

In the past, patients have had to undergo a spinal fluid test to discern whether the symptoms they are experiencing are in fact the result of Parkinson’s. The new discovery, which was made during research by scientists at Sweden’s Lund University, could be a big step forward in understanding the disease.

Some 127,000 people, mainly in middle-age or elderly, are believed to have Parkinson’s disease. Symptoms include slow movement, tremors and rigidity of the muscles, making everyday tasks hard to complete.

While there are currently no cures for the disease, early diagnosis is key in controlling the symptoms and helping patients live as ordinary lives as possible. Progressive nerve cell damage is thought to begin before symptoms appear and a diagnosis can be sought.

There are other conditions that display similar symptoms to those produced by Parkinson’s disease, making tests of fluid the best way to discern the difference. Blood is much simpler to extract than spinal fluid, however, and should be less uncomfortable for the patient.

Dr Oskar Hansson, leader of the study, said: “We have found that concentrations of a nerve protein in the blood can discriminate between these diseases as accurately as concentrations of that same protein in spinal fluid.”

Throughout the research, the scientists tested the blood of 504 people, including healthy participants and those who have been diagnosed with the disease for up to six years. Results showed that the blood tests were as accurate at the spinal fluid tests in discerning between Parkinson’s and other neurological diseases.

Dr Hansson added: “Our findings are exciting because when Parkinson's or an atypical parkinsonism disorder is suspected, one simple blood test will help a physician to give their patient a more accurate diagnosis.”

Claire Bale, head of research communications at Parkinson's UK, welcomed the development, stating that it could cut down on the stress and delays that come with getting a definitive diagnosis. It is thought that around one in ten people diagnosed with Parkinson’s actually have a different condition.

This means they do not receive the right treatment from the outset and clinical trials into new drugs to tackle Parkinson’s are therefore flawed. More research with bigger study groups needs to be done into the blood test, but it is a step forward in the route to diagnosis for potential Parkinson’s patients.

Coronavirus: visitor guidance

To support our residents, patients and staff during this period of uncertainty with coronavirus COVID-19, we are asking for your help and support as we are asking that we have no visitors, except healthcare professionals.

This is to ensure that we keep you and your loved ones as safe as possible as we know that this virus is very contagious. We will still ensure that vital medical visits are made ensuring that they wash their hands on entering and we will be asking all visitors to ensure they have no symptoms and will be taking their temperature.

All of our homes and hospitals have now been set up for Skype calling to enable you to keep in touch and we are confident that our staff will do all they can to ensure that life in our services remains as comfortable and sociable as possible as we support them with delivering interactive activities, whilst practicing physical distancing.

We understand that this is a worrying time for you, and we want to reassure you that we are doing everything we can to ensure that our residents, patients and staff are as safe as possible, and we are staying close to the advice from public health authorities.

If you have any questions please do not hesitate to contact us on our helpline on coronahelpline@Barchester.com and please call the home or hospital if you would like to speak to a loved one.